28-joint Count Disease Activity Score (DAS28-ESR) Remission (<2.6) at Both Week 20 and Week 24;Simplified Disease Activity Index (SDAI) Remission (≤3.3) at Both Week 20 and Week 24;Time From Stopping Treatment (Week 24) to Loss of Remission (up to Week 52) Assessed Using Clinical Disease Activity Index (CDAI) Scores at 2 Consecutive Visits;Time From Stopping Treatment (Week 24) to Loss of Remission (up to Week 52) Assessed Using Simplified Disease Activity Index (SDAI) Scores at 2 Consecutive Visits;Time From Stopping Treatment (Week 24) to Loss of Remission (up to Week 52) Assessed Using DAS28-ESR Scores at 2 Consecutive Visits;American College of Rheumatology 20% (ACR20) Response at Week 24;American College of Rheumatology 50% (ACR50) Response at Week 24;American College of Rheumatology 70% (ACR70) Response at Week 24;Change From Baseline in Health Assessment Questionnaire Disability Index (HAQ-DI) at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Physical Component Summary (PCS) Scores at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Mental Component Summary (MCS) Scores at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Physical Functioning Domain at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Role Physical Domain at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Bodily Pain Domain at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) General Health Domain at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Vitality Domain at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Social Functioning Domain at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Role Emotional Domain at Week 24;Change From Baseline in Short Form 36-items Health Survey (SF-36) Mental Health Domain at Week 24;Change From Baseline in Patient's Assessment of Arthritis Pain-Visual Analog Scale (VAS) at Week 24;Change From Baseline in Patient's Global Assessment of Disease Activity - Visual Analog Scale (PtGADA-VAS) at Week 24;Change From Baseline in Fatigue Assessment Scale at Week 24